natural products] as starting materials for the synthesis of estrone and estradiolsteroid hormones that had not been part of his synthetic repertoire." 4 Marker had successfully produced progesterone from the sapogenins diosgenin and sarsasapogenin (Figure 1 ), but none of the known plant sources yielded sufficient quantities of sapogenins to be cost-effective for industry. The intrepid chemist then began a search for better sapogenin sources which led to a Mexican species of yam (Dioscorea mexicana). Pharmaceutical companies spurned his discoveries, so Marker moved to Mexico and started Syntex, S.A. in 1944. His involvement with Syntex was short, and, following a quarrel with his partners, he soon left the company. Syntex floundered without Marker's expertise and lab notes, until the company hired George Rosenkranz, who recruited Carl Djerassi and other talented chemists. 5 After joining Syntex in 1949, Djerassi synthesized both cortisone and norethisterone, a progesterone mimic, from diosgenin extracted from Dioscorea mexicana. 6 The role of plants in supplying the starting material for subsequent modifications is unquestioned and is noted by physicians, historians, and scientists, including Djerassi himself: "Interestingly, this genesis of estrogens ... led us in a fairly straight path to the first synthesis of an oral contraceptive in the same year (1951) in which we also announced the first synthesis of cortisone from a plant raw materialat that time arguably the hottest problem in synthetic organic chemistry." 4 Plants continued to play a vital role in the steroid industry after the initial euphoria of the 1940s and early 1950s. Another plant steroidal saponin, hecogenin, was first discovered in the terrestrial bromeliad Hechtia texensis (Bromeliaceae). It also occurs in the cultivated species sisal (Agave sisalana, Asparagaceae), which is the source of the fiber of the same name. Syntex pioneered the production of cortisone from sisalderived hecogenin. 7 The Mexican company licensed the process to Glaxo, which developed top selling drugs, including betamethasone and beclomethasone. 3 Both have been on the World Health Organization's list of essential medicines, and many other drugs on the list are either plant derived or based on chemical structures first identified in the botanical kingdom (e.g., artemether, Artemisia annua; etoposide and teniposide, Podophyllum peltatum).
Chemists' blindness toward plants stems from the term synthesis. When they describe the "synthesis" of a compound from or based on the structure of a natural product, they conceal the diversity of nature's chemical palette and disregard the role of natural products. Plants continue to be the source of new lead compounds as well as new drugs. The work of many Nobel prize-winning chemists from Hermann Fischer's sugar and purine syntheses (1902) to Elias Corey's organic syntheses, including ginkgolides (1990), has been based, at least in part, on plant natural products. Let us not forget the importance of plants as sources of compounds for chemistry, medicine, and industry.
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